All Stories

  1. Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma
  2. Validation of the Diagnostic and Prognostic Values of ADAMTS5 and FSTL1 in Osteoarthritis Rat Model
  3. Lesional and circulating levels of interleukin-17 and 25-hydroxycholecalciferol in active acne vulgaris: Correlation to disease severity
  4. Expression profiles of TRPV1, TRPV4, TLR4 and ERK1/2 in the dorsal root ganglionic neurons of a cancer-induced neuropathy rat model
  5. Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis
  6. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model
  7. Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors
  8. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib
  9. Design, synthesis and pharmacophoric model building of new 3-alkoxymethyl/3-phenyl indole-2-carboxamides with potential antiproliferative activity
  10. Zinc oxide nanoparticles as a novel anticancer approach; in vitro and in vivo evidence
  11. Circulating Survivin and TIMP-1 in Hepatitis C Virus Associated Liver Fibrosis
  12. A Novel Model of Cancer-Induced Peripheral Neuropathy and the Role of TRPA1 in Pain Transduction
  13. Survivin as a Novel Biomarker in the Pathogenesis of Acne Vulgaris and Its Correlation to Insulin-Like Growth Factor-I
  14. Priority of Alpha-L- Fucosidase Over Alpha fetoprotein in Early Detection of Hepatocellular Carcinoma in Animals and Human
  15. Clinical impact of serum proteins on drug delivery
  16. Impact of albumin on drug delivery — New applications on the horizon
  17. Serum Proteins as Drug Carriers of Anticancer Agents
  18. Implication of Umbilical Cord in Preeclampsia
  19. Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study
  20. In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP)
  21. Optimization of an Albumin-Binding Prodrug of Doxorubicin That Is Cleaved by Prostate-Specific Antigen
  22. Abstract LB-38: Evaluation of a PSA cleavable doxorubicin prodrug in thein vitroandin vivoLNCaP LN model
  23. Abstract LB-39: Development of a novel water-soluble prodrug of paclitaxel that is cleaved by prostate-specific antigen (PSA):In vitroandin vivoevaluation